NASHUA, N.H., March 7 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced the company will demonstrate its latest CAD innovations at the second-largest radiological meeting in the world, the European Congress of Radiology (ECR), in Vienna, Austria, March 7 to 11 (booth #108).
At ECR, iCAD plans to showcase its SecondLook(R) suite of products, including an enhanced version of SecondLook Digital for Siemens. The technology now provides more detailed information about marked regions of interest and displays CAD marks based upon the certainty of the finding.
Additionally, customized SecondLook Digital CAD solutions for Agfa CR, Sectra and Planmed digital mammography systems will be displayed in iCAD's booth. SecondLook Digital will broaden and strengthen these solutions by providing enhanced detection and workflow capabilities, and will deliver powerful performance improvements increasing the radiologist's confidence.
iCAD also continues to develop CAD applications for CT Colonography and Tomosynthesis, and works-in-progress will be demonstrated in the booth. While still in development, these CAD solutions have the potential to provide superior identification capabilities and assist in improving accuracy and workflow during the reading process.
"Through pursuit of diverse partnerships and research of new applications, iCAD is expanding the opportunities for CAD, and we are excited to demonstrate this progress to the European audience at ECR," said Ken Ferry, President and Chief Executive Officer of iCAD. "As the market for CAD continues to grow, iCAD is committed to the continuous development and enhancement of products to improve the accuracy and consistency of cancer detection."
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over 1800 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com
For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at icad@lhai.com
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at icad@schwartz-pr.com
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
CONTACT: Darlene Deptula-Hicks, EVP and CFO of iCAD, Inc., +1-603-882-5200
ext. 7944, ddeptula@icadmed.com; Investor Relations: Anne Marie Fields of
Lippert-Heilshorn & Associates, +1-212-838-3777 ext. 6604, icad@lhai.com;
or Public Relations: Wendy Ryan of Schwartz Communications,
+1-781-684-0770, icad@schwartz-pr.com, both for iCAD, Inc.
Web site: http://www.icadmed.com/
